Early signs of recovery as the deal volumes increase significantly is the anticipation of Moore Kingston Smith Corporate Finance.
The Coronavirus Future Fund has provided a major boost to the UK growth capital market, and we have seen deal activity increase by 28% in Q3 2020.
Businesses with scalable software and technology solutions continued to be popular with investors as did biotechnology and healthcare companies.
The extension of the Future Fund into Q4 and beyond creates an extremely benign environment for those seeking capital to fund their further expansion.
Comments